Brief: Spruce Biosciences Reports Fourth Quarter And Full Year 2021 Financial Results

Spruce Biosciences

14/03/2022 20:14

March 14 (Reuters) - Spruce Biosciences Inc  SPRB.O :
    * SPRUCE BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES
    * TOPLINE SAFETY DATA FROM COHORT 1 OF PHASE 2 PEDIATRIC
CLASSIC
CAH STUDY EXPECTED BY 1H 2023
    * SPRUCE BIOSCIENCES- CASH, CASH EQUIVALENTS, INVESTMENTS AS
OF
DEC 31, 2021, WERE $121.4 MILLION, WHICH MANAGEMENT ANTICIPATES
FUNDS CO INTO Q2 OF 2024
    * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.39
    * Q4 EARNINGS PER SHARE VIEW $-0.54 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBwWR1ZPa 
Further company coverage:  SPRB.O 

 ((reuters.briefs@thomsonreuters.com;))